08
Oct
Global Business News — October 08, 2026 — Evening Update — Last 12 Hours (Pacific Time)
FDA approves Tecentriq for stage III colon cancer and Raytheon wins $6.3B missile defense contract. Meanwhile, biotech IPOs surge with TRex Bio and Retension Pharmaceuticals pricing, while Green AI Cloud and Quantisimo pursue SPAC mergers in a busy capital markets session.
7 min read